Abstract
This study compared pharmacokinetic profiles in cattle dosed subcutaneously with two different formulations of enrofloxacin (5% and 10%) at a dose of 5 mg/kg. Plasma concentrations of enrofloxacin and its active metabolite, ciprofloxacin, were determined by a HPLC/u.v. method. The pharmacokinetic parameters of enrofloxacin and its metabolite were similar in both injectable formulations. Enrofloxacin peak plasma concentration (5%: 0.73 ± 0.32; 10%: 0.60 ± 0.14 μg/mL) was reached at 1.21 ± 0.52 and 1.38 ± 0.52 h to 5 and 10%, respectively. The terminal half-live and area under curve were 2.34 ± 0.46 and 2.59 ± 0.46 h, and 3.09 ± 0.81 and 2.93 ± 0.58 μg·h/mL, to 5 and 10%, respectively. The AUC/MIC90 and Cmax/MIC90 ratios for both formulations exceed the proposed threshold values for optimized efficacy and minimized resistance development whilst treating infections or septicaemia caused by P. multocida and E. coli.
References
De Lucas, J.J., Rodríguez, C., Waxman, S., González, F., de Vicente, M.L. and San Andrés, M.I., 2004. Pharmacokinetics of enrofloxacin after single intravenous and intramuscular administration in young domestic ostrich (Struthio camelus), Journal of Veterinary Pharmacology and Therapeutics, 27, 119–122.
Gandolf A.R., Papich, M.G., Bringardner, A.B. and Atkinson, M.W., 2005. Pharmacokinetics after intravenous, subcutaneous, and oral administration of enrofloxacin to alpacas, American Journal of Veterinary Research, 66, 767–771.
Grobbel, M., Lübke-Becker, A., Wieler, L. H., Froyman, R., Friederichs, S. and Filios, S., 2007. Comparative quantification of the in vitro activity of veterinary fluoroquinolones. Veterinary Microbiology, 124, 73–81.
Hoeben, B.D., Monfardini, E., Burvenich, C. and Hamann, J., 2000. Treatment of acute Escherichia coli mastitis in cows with enrofloxacin: effect on clinical signs and chemiluminescence of circulating neutrophils, Journal of Dairy Research, 67, 485–502.
Kaartinen, L., Salonen, M., Älli, L. and Pyörälä, S., 1995. Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows, Journal of Veterinary Pharmacology and Therapeutics 18, 357–362.
McKellar, Q.A., 1996. Clinical relevance of pharmacologic properties of fluoroquinolones, Compendium on Continuing Education for the Practicing Veterinarian, 18(Suppl.), 14–21.
McKellar, Q.A., Gibson, I., Monteiro, A. and Bregante, M., 1999. Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration. Antimicrobial Agents and Chemotherapy. 43, 1988–1992.
McKellar, Q.A., Sánchez-Bruni, S.F. and Jones, D.G., 2004. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 27, 503–514.
Prescott, J.F. and Yielding, K.M., 1990. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Canadian Journal of Veterinary Research, 54, 195–197.
Rahal, A., Kumar, A., Ahmad, A.H., Malik, J.K. and Ahuja, V., 2006. Pharmacokinetics of enrofloxacin in sheep following intravenous and subcutaneous administration. Journal of Veterinary Pharmacology and Therapeutics, 29, 321–324.
Ramesh, S., Rao, G.S. and Malik, J.K., 2002: Pharmacokinetic disposition of subcutaneously administered enrofloxacin in goats. Veterinary Research Communications, 26, 563–569.
Wallmann, J., 2006. Monitoring of antimicrobial resistance in pathogenic bacteria from livestock animals. International Journal of Medical Microbiology, 296 S2, 81–86.
Acknowledgments
The authors thank Mr. Mariano Díaz-Flores for his technical assistance. Thanks to the staff of the Biblioteca de la Facultad de Veterinaria (BUCM) for their invaluable help. This study was supported by a grant from the Bayer Health Care, AG (348/2001 Art. 83 LRU/UCM). Special thanks to Mr Enrique Rierola, from Química Farmacéutica Bayer, S.A. (Barcelona, Spain) and Ms. Isabel Uriarte Inchausti (DVM).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Lucas, J.J., San Andrés, M.I., González, F. et al. Pharmacokinetic behaviour of enrofloxacin and its metabolite ciprofloxacin after subcutaneous administration in cattle. Vet Res Commun 32, 275–279 (2008). https://doi.org/10.1007/s11259-008-9037-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11259-008-9037-y